Medicare Reform Using Part D Model Is Advocacy Priority For PhRMA – Castellani
For PhRMA, supporting a move toward privatizing Medicare is a tactic that may help avoid the establishment of new price controls in the system, like the often-discussed mandated drug rebates in Part D.
You may also be interested in...
Rep. Kevin Brady, new chairman of the House panel’s Health Subcommittee, says he will move ahead with a premium support system for Medicare, an approach to reform favored by PhRMA. Savings generated by that change will offset the cost of repealing the sustainable growth rate formula for Medicare physician payments.
Rep. Pete Stark, D-Calif., often a critic of the pharmaceutical industry, lost his re-election bid, leaving the top Democratic spot open on the Ways and Means Committee’s Health Subcommittee. Subcommittee Chairman Wally Herger already planned to retire. All members of the Senate HELP and Finance Committees up for re-election won their races.
In her appearance at the convention in Charlotte, N.C., on Sept. 4, HHS Secretary Kathleen Sebelius promoted the benefits of the Affordable Care Act and sought to draw a distinction between the plan for Medicare embodied in the ACA and that advanced by Republican presidential candidate Mitt Romney.